Abiraterone Acetate Tablet
Product Images NDC 42291-073

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Abiraterone Acetate (NDC 42291-073). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

500 (073 60 500mg)

Label for Abiraterone Acetate Tablets, USP 500 mg, manufactured by AvKARE. The label indicates the package contains 60 tablets for oral use. Additional text outlines storage conditions and notes the product is prescription only (Rx Only). The label includes an NDC number 42291-073-60 and a barcode.*

FDA Label Image

1 (Abiraterone Acetate Tablets 250mg 500mg 1)

Chemical structure diagram of abiraterone, the active ingredient in ABIRATERONE ACETATE 500 mg oral tablets by AvKARE, showing its steroidal framework with attached functional groups including acetoxy and pyridine rings.*

FDA Label Image

Figure 1 (Abiraterone Acetate Tablets 250mg 500mg 2)

Kaplan-Meier survival curve comparing percentage survival over time (months) between two groups: one treated with Abiraterone Acetate and the other with placebo. The x-axis shows time to death in months, and the y-axis shows percent survival. The graph includes patient numbers at risk at several time points for both groups.*

FDA Label Image

Figure 2 (Abiraterone Acetate Tablets 250mg 500mg 3)

A survival curve chart showing the percentage of subjects without death over 60 months from randomization, comparing Abiraterone Acetate with placebo. The x-axis represents months from randomization, and the y-axis shows the percentage of subjects without death. Two lines represent the survival rates for each group, with numerical data for subjects at various time points displayed below the x-axis.*

FDA Label Image

Figure 3 (Abiraterone Acetate Tablets 250mg 500mg 4)

A Kaplan-Meier survival curve graph illustrating the percentage of subjects without radiographic progression or death over months from randomization, comparing Abiraterone Acetate and placebo groups. The x-axis shows time in months from 0 to 18, and the y-axis shows percentage of subjects from 0% to 100%. Two lines represent the treatment groups: a solid line for Abiraterone Acetate and a dashed line for placebo, with subject counts listed below each time interval.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.